DrugPatentWatch Database Preview

Details for Patent: 8,747,896

Which drugs does patent 8,747,896 protect, and when does it expire?

Patent 8,747,896 protects SITAVIG and is included in one NDA.

This patent has twenty-six patent family members in twenty-four countries.

Summary for Patent: 8,747,896

Title:	Mucosal bioadhesive slow release carrier for delivering active principles
Abstract:	A mucosal bioadhesive slow release carrier comprising an active principle and devoid of starch, lactose, which can release the active principal for a duration of longer than 20 hours. This bioadhesive carrier contains a diluent, an alkali metal alkylsulfate, a binding agent, at least one bioadhesive polymer and at least one sustained release polymer, as well as a method for its preparation.
Inventor(s):	Costantini; Dominique (Paris, FR), Lemarchand; Caroline (Paris, FR)
Assignee:	BioAlliance Pharma (Paris, FR)
Application Number:	13/565,653
Patent Claim Types: see list of patent claims	Formulation; Delivery; Use;

Drugs Protected by US Patent 8,747,896

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Epi Hlth	SITAVIG	acyclovir	TABLET;BUCCAL	203791-001	Apr 12, 2013		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			TREATMENT OF HERPES LABIALIS	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted

Foreign Priority and PCT Information for Patent: 8,747,896

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	06290480	Mar 24, 2006

Non-Orange Book US Patents Family Members for Patent 8,747,896

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
8,211,466	Mucosal bioadhesive slow release carrier for delivering active principles	➤ Sign Up
8,791,127	Mucosal bioadhesive slow release carrier for delivering active principles	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration

International Patents Family Members for US Patent 8,747,896

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	060085	➤ Sign Up
Austria	446743	➤ Sign Up
Australia	2007231029	➤ Sign Up
Brazil	PI0709057	➤ Sign Up
Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Summary for Patent: 8,747,896

Foreign Priority and PCT Information for Patent: 8,747,896

For more information try a trial or see the plans and pricing